V březnu se zúčastníme celoslovenské genetické konference, která se koná 16. - 17. 3. 2022 v hotelu Turiec ve slovenském Martině. Konferenci pořádá Slovenská společnost lékařské genetiky a je již trad...
VíceNavštivte nás na Genetické konferenci pořádané Genetickou společností Gregora Mendela. Tento rok proběhne v termínu 5. - 7. 10. společně s konferencí Genetické dny, jež se konají ve dvouletých interva...
VícePřijďte se na nás podívat na Celostátní sjezd Společnosti lékařské genetiky a genomiky ČLS JEP a 55. výroční cytogenetickou konferenci, jež se koná ve Wellness Hotelu Step 15. a 16. září. Rádi se s Vá...
VíceReal-Time PCR Assay for Detection of 2 High-risk HPVs and 2 low-risk HPVs
Human papillomavirus (HPV) is a sexually transmitted DNA virus that establishes infection in squamous epithelialcells in the human body. There are more than 200 types of HPV, which can be classified into high or low-risktypes depending upon their oncogenic potentials.High-risk HPVs also called oncogenic HPVs, which have been confirmed to cause cancer. Low-risk HPVs can cause genital warts and low-grade changes in thecells, but rarely cause cancer.
The most common HPV types that infect the human body are HPV types 6, 11, 16 and 18. HPV6 and HPV11 are most commonly associated with benign lesions such as genital warts and mild dysplasia of the cervix. HPV16 and HPV18 are known to cause around 70% of cervical cancer cases. Currently there is HPV quadrivalent vaccine that could protect against HPV types 6, 11, 16 and 18, and is recommended primarily for those women not yet having been exposed to HPV.
Intended Use:
The kit is intended for qualitative detection of two high-risk HPV types 16/18 and two low-risk HPV types 6/11.